30 million has been spent on 1102 which is just over half the companies accumulated losses. Now that they have finally cleared up the tox study with the FDA - giving all data the green light , licensing is the next step and they can begin recouping that large amount of capital spent.
Seriously where else on the planet is anyone going to find a ready made treatment for Ms that compares with Tysabri and includes a thumbs up from the FDA ???
It will sink in sooner or later but ANP has 2 late stage drugs both efficacious and safe and the company is currently in negotiations.
what else could you want at this ridiculous price?
ANP Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)